← Back to Clinical Trials
Recruiting NCT05833555

NCT05833555 Harlem Strong Mental Health Coalition

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05833555
Status Recruiting
Phase
Sponsor City University of New York, School of Public Health
Condition Stress-related Problem
Study Type INTERVENTIONAL
Enrollment 700 participants
Start Date 2023-04-05
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
MH task-sharing trainingSupervisionLearning Collaborative

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 700 participants in total. It began in 2023-04-05 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Addressing health disparities, especially in the face of coronavirus pandemic, requires an integrated multi-sector equity-focused, community-based approach. This study will examine the impact of Harlem Strong Community Mental Health Collaborative, a community-wide multi-sectoral coalition in which a health insurer works with a network of community-based organizations, medical providers, and behavioral health providers to engage in a network-wide implementation planning process to: (1) problem-solve financing, access, and quality of care barriers, (2) support capacity building for mental health (MH) task-sharing for community health workers, (3) facilitate coordination and collaboration across MH/behavioral health, primary care, and a range of social services, including case management, housing supports, financial education, employment support, and other community resources to improve linkages to services, and (4) identify a set of common MH, social risk, and health metrics and strategies to integrate these metrics into data systems across the network for continuous quality improvement of the system. The long-term goal of our study is to develop sustainable model for task-sharing MH care that will be embedded in a coordinated comprehensive network of services, including primary care, behavioral/MH, social services, and other community resources.

Eligibility Criteria

Inclusion Criteria: * Black and Latino adults between 18 and 65 years * Harlem residents from low-income housing developments or receiving primary care services in Harlem * PHQ-4 Total Score ≥3, moderate risk for depression Exclusion Criteria: * Those with risk for depression or anxiety who screen positive for severe mental illness (e.g., psychosis, mania, substance abuse, and high suicide risk) using screening items from the Mini-International Neuropsychiatric Interview will be excluded from the study and referred to MH services at higher levels of care

Contact & Investigator

Central Contact

Srividhya Sharma, PhD, MPH

✉ Srividhya.Sharma@sph.cuny.edu

📞 347-395-7943

Principal Investigator

Victoria K Ngo, PhD

PRINCIPAL INVESTIGATOR

City University of New York

Frequently Asked Questions

Who can join the NCT05833555 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Stress-related Problem. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05833555 currently recruiting?

Yes, NCT05833555 is actively recruiting participants. Contact the research team at Srividhya.Sharma@sph.cuny.edu for enrollment information.

Where is the NCT05833555 trial being conducted?

This trial is being conducted at New York, United States, New York, United States.

Who is sponsoring the NCT05833555 clinical trial?

NCT05833555 is sponsored by City University of New York, School of Public Health. The principal investigator is Victoria K Ngo, PhD at City University of New York. The trial plans to enroll 700 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology